Literature DB >> 6327444

The interaction of anticholinesterase agents with the acetylcholine receptor-ionic channel complex.

E X Albuquerque, A Akaike, K P Shaw, D L Rickett.   

Abstract

The actions of pyridostigmine (Pyr), a quaternary carbamate compound, and physostigmine ( Phy ), a tertiary carbamate, both known for their reversible inhibition of acetylcholinesterase (AChE), were studied on the electrically excitable membrane and acetylcholine (ACh) receptor of the frog cutaneous pectoris, sartorius, and interosseal muscles, as well as the chronically denervated soleus muscle of the rat and myoballs from neonatal rats. Both Pyr and Phy first potentiated, then depressed and finally blocked the indirectly evoked muscle twitch. Pyr and Phy had negligible effects upon either membrane potential or muscle action potential. But at the synaptic junction, they decreased the peak amplitude of the endplate current (EPC) in a voltage- and concentration-dependent manner. Pyridostigmine produced a marked prolongation of the decay time constants of both the EPC and the miniature endplate current ( MEPC ), while maintaining a single exponential decay, and Phy decreased peak amplitude, while having little effect on its voltage dependence. Physostigmine also decreased the decay time constant, suggesting a channel block, presumably in open state. Single channel recordings using patch clamp techniques disclosed that Pyr interacts with the ACh receptor as a weak agonist capable of inducing desensitization, alone, and when combined with ACh. Physostigmine interacts directly with the ACh-ionic channel complex, blocking it in open conformation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6327444     DOI: 10.1016/0272-0590(84)90135-0

Source DB:  PubMed          Journal:  Fundam Appl Toxicol        ISSN: 0272-0590


  9 in total

1.  Effects of organophosphorus anticholinesterases on nicotinic receptor ion channels at adult mouse muscle endplates.

Authors:  J E Tattersall
Journal:  Br J Pharmacol       Date:  1990-10       Impact factor: 8.739

2.  The effect of chronic neostigmine treatment on channel properties at the rat skeletal neuromuscular junction.

Authors:  M Gwilt; D Wray
Journal:  Br J Pharmacol       Date:  1986-05       Impact factor: 8.739

3.  Pyridostigmine but not 3,4-diaminopyridine exacerbates ACh receptor loss and myasthenia induced in mice by muscle-specific kinase autoantibody.

Authors:  Marco Morsch; Stephen W Reddel; Nazanin Ghazanfari; Klaus V Toyka; William D Phillips
Journal:  J Physiol       Date:  2013-02-25       Impact factor: 5.182

4.  Activation and block of the adult muscle-type nicotinic receptor by physostigmine: single-channel studies.

Authors:  Julius Militante; Bei-Wen Ma; Gustav Akk; Joe Henry Steinbach
Journal:  Mol Pharmacol       Date:  2008-06-03       Impact factor: 4.436

5.  Nicotinic receptors differentially modulate the induction and expression of behavioral sensitization to methylphenidate in rats.

Authors:  Thomas E Wooters; Michael T Bardo
Journal:  Psychopharmacology (Berl)       Date:  2009-02-20       Impact factor: 4.530

6.  Synthesis of the Alzheimer drug Posiphen into its primary metabolic products (+)-N1-norPosiphen, (+)-N8-norPosiphen and (+)-N1, N8-bisnorPosiphen, their inhibition of amyloid precursor protein, α-Synuclein synthesis, interleukin-1β release, and cholinergic action.

Authors:  Qian-Sheng Yu; Marcella Reale; Mohammad A Kamal; Harold W Holloway; Weiming Luo; Kumar Sambamurti; Balmiki Ray; Debomoy K Lahiri; Jack T Rogers; Nigel H Greig
Journal:  Antiinflamm Antiallergy Agents Med Chem       Date:  2013

Review 7.  Monitoring of neuromuscular function in the clinical setting.

Authors:  D Kelly; S J Brull
Journal:  Yale J Biol Med       Date:  1993 Sep-Oct

8.  Physiologically based pharmacokinetic model for the inhibition of acetylcholinesterase by organophosphate esters.

Authors:  J M Gearhart; G W Jepson; H J Clewell; M E Andersen; R B Conolly
Journal:  Environ Health Perspect       Date:  1994-12       Impact factor: 9.031

Review 9.  Toxicity of the organophosphate chemical warfare agents GA, GB, and VX: implications for public protection.

Authors:  N Munro
Journal:  Environ Health Perspect       Date:  1994-01       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.